Stock Region Penny Picks
Stock Region Penny Picks Watchlist: Thursday, November 13, 2025
Stock Region Penny Picks Watchlist: Thursday, November 13, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This is a watchlist. The information provided is for educational and entertainment purposes only. It is not financial advice, and you should not construe it as such. Always do your own research and consult with a licensed financial advisor before making any investment decisions. We may or may not hold positions in the stocks mentioned below.
What a day yesterday. The market gave us a mix of everything—big pharma moves, AI mania continuing its run, and some classic earnings beats and misses. Let’s break down the tickers that are catching our eye and should definitely be on your radar today.
$MGRX - Mangoceuticals
These guys are making a huge play. They’ve partnered with Eli Lilly and Novo Nordisk to help provide affordable access to the blockbuster weight-loss drugs Zepbound and Wegovy. This is massive. Tapping into the obesity management market, which is exploding, by aligning with the two biggest names in the space? That’s a brilliant move. I’m watching this to see how the market digests the long-term revenue potential here. This could be a game-changer for $MGRX if they execute well.
$BWEN - Broadwind
Talk about a glow-up. Broadwind dropped their Q3 results and they are shining. Orders are up 90% year-over-year to $43.6 million. That’s not just growth; that’s an explosion. They even raised their full-year revenue guidance for 2025. When a company feels confident enough to raise guidance this late in the year, you have to pay attention. It tells me they see a clear path to continued success.
$CHAI - Core AI
Just when you thought the AI hype might cool down, $CHAI comes in and pours gasoline on the fire. A $5 billion global AI data center initiative? The sheer scale of this announcement is staggering. Money is flooding into AI infrastructure, and Core AI just signaled they are ready to be a major player. This is the kind of headline that can create a multi-day runner. Keep this one on your main screen.
$LRHC - La Rosa Holdings Corp.
Speaking of AI data centers, here’s another one jumping into the fray. $LRHC just secured up to $1.25 billion in financing to pivot into AI data center infrastructure. It seems like everyone wants a piece of this pie, and La Rosa is coming in hot. It’s a bold, strategic shift, and with that kind of financing, they’re not messing around. It feels like a high-risk, high-reward situation, which is exactly the kind of volatility we love to trade.
$ONDS - Ondas Holdings
Ondas reported record Q3 results and the outlook is looking strong. They’re talking robust growth, strategic execution, and massive global demand for their autonomous drone systems. Drones are the future, from surveillance to delivery, and Ondas is positioning itself right in the middle of it. A record quarter is great, but the bullish outlook is what really has my attention.
$TNMG - TNL Mediagene
This one absolutely ripped yesterday, popping 79% after announcing a strategic partnership with Coupang. Coupang is a giant in e-commerce, and any time a small-cap company links up with a behemoth like that, fireworks are expected. The question now is, can it hold these gains and build momentum? Watch for profit-taking this morning, but this partnership could have long-term legs.
$SINT - SINTX Technologies
SINTX had a pivotal Q3, driven by FDA clearance and portfolio expansion. FDA news is always a major catalyst, and it seems to be paying off for them. They also mentioned “increased operational efficiencies,” which is corporate-speak for “we’re getting better at making money.” I like seeing that. This could be the start of a significant turnaround story.
$GAME - GameSquare Holdings
Finally, a gaming stock with a clean balance sheet and actual net income! GameSquare reported a solid Q3 with $5.9 million in net income from continuing operations. Their gross margin is up, and they have the strongest balance sheet in the company’s history with zero debt. In this economy, a company that’s both growing and financially disciplined is a rare gem.
A Few Others on the Radar:
$CAPS: Expanding its distribution platform amid “strong market tailwinds.” Vague, but positive. Worth keeping an eye on for more concrete news.
$CMND: Got final approval to expand its FDA trial for an Alcohol Use Disorder treatment. Progress in clinical trials is always a good sign for biotech.
$NVVE: Teaming up with PG&E and Nissan on vehicle-to-grid tech. This is a super interesting, forward-thinking EV play that isn’t just about making cars.
$AMRX: Another FDA approval, this time for their Iohexol Injection. Consistent approvals build a strong foundation.
$BTOC: Revenue growth of 16.5% is solid. Nothing earth-shattering, but steady growth is healthy.
$LAZR: A mixed bag here. They beat on earnings per share (lost less money than expected) but missed on revenue. The market hates revenue misses. This could see some downward pressure.
That’s the list for today. Trade smart, stick to your plan, and let’s go make some money.
Final Disclaimer: Remember, investing in the stock market involves risk, including the loss of principal. The stocks mentioned here are for discussion purposes only and are not recommendations to buy or sell. Past performance is not indicative of future results. Do your own due diligence.